LabCorp Drug Development Services
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:acquisition |
gptkb:Laboratory_Corporation_of_America_Holdings
|
| gptkbp:employs |
scientists
clinical research associates |
| gptkbp:established |
1971
|
| gptkbp:has_a |
clinical research
clinical sites |
| gptkbp:has_a_focus_on |
patient safety
therapeutic areas real-world evidence |
| gptkbp:has_a_mission_to |
improve patient outcomes
|
| gptkbp:has_expertise_in |
Phase III trials
regulatory affairs Phase I trials Phase II trials Phase IV trials |
| gptkbp:has_partnerships_with |
academic institutions
|
| gptkbp:headquarteredIn |
gptkb:Burlington,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
LabCorp Drug Development Services
|
| gptkbp:is_committed_to |
innovation
ethical standards |
| gptkbp:is_involved_in |
global clinical trials
biomarker_development |
| gptkbp:is_known_for |
fast turnaround times
scientific rigor |
| gptkbp:is_part_of |
gptkb:LabCorp
|
| gptkbp:is_recognized_for |
comprehensive solutions
|
| gptkbp:leadership |
drug development services
|
| gptkbp:number_of_teams |
experienced professionals
|
| gptkbp:offers |
consulting services
medical writing services laboratory services biostatistics services regulatory submission services data_analytics_services |
| gptkbp:offersServices |
biotechnology companies
|
| gptkbp:operates_in |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:provides |
clinical trials
customized solutions data management services patient recruitment services pharmacovigilance services site management services quality assurance services clinical trial services |
| gptkbp:serves |
pharmaceutical companies
|
| gptkbp:specializesIn |
drug development
|
| gptkbp:utilizes |
advanced technology
|